PENTHROP Inhalation solution Ref.[50526] Active ingredients:

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2021  Publisher: Equity Pharmaceuticals (Pty) Ltd., 100 Sovereign Drive, Route 21 Corporate Park, Nellmapius Drive, Irene, Pretoria

Product name and form

PENTHROP, 99,9% m/m, inhalation.

Pharmaceutical Form

Inhalation.

Clear, practically colourless, mobile liquid, having a characteristic odour.

Qualitative and quantitative composition

Each ml of Penthrop contains 99,9% m/m methoxyflurane.

Antioxidant: 0,01% m/m butylated hydroxytoluene.

For full list of excipients, see section 6.1.

List of Excipients

Butylated hydroxytoluene

Pack sizes and marketing

3 ml of PENTHROP solution is filled into a 5 ml Type I amber glass screw neck bottle and closed with a white cap. PENTHROP is supplied in the following presentations:

  • Combination pack containing one sealed bottle filled with 3 ml liquid, one PENTHROP inhaler and one Activated Carbon chamber in an outer carton box (pack of 1 or 10 units).
  • Combination pack containing one sealed bottle filled with 3 ml liquid and one PENTHROP inhaler in an outer carton box (pack of 10 units).

Marketing authorization holder

Equity Pharmaceuticals (Pty) Ltd., 100 Sovereign Drive, Route 21 Corporate Park, Nellmapius Drive, Irene, Pretoria

Marketing authorization dates and numbers

45/2.9/1118

Date of registration: 5 June 2014

Drugs

Drug Countries
PENTHROP Austria, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈